JW Pharmaceutical Corporation (KRX:001060)

Market Cap	826.01B +55.0%
Revenue (ttm)	764.21B +3.8%
Net Income	57.97B -14.5%
EPS	2,508.80 -15.8%
Shares Out	22.89M
PE Ratio	14.43
Forward PE	n/a
Dividend	450.00 (1.24%)
Ex-Dividend Date	Mar 31, 2026

Volume	99,553
Average Volume	183,340
Open	35,800
Previous Close	36,200
Day's Range	35,200 - 36,400
52-Week Range	19,600 - 39,250
Beta	1.12
RSI	61.87
Earnings Date	Mar 13, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,068
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001060

Financial Performance

In 2024, JW Pharmaceutical's revenue was 719.38 billion, a decrease of -3.89% compared to the previous year's 748.53 billion. Earnings were 60.78 billion, an increase of 64.24%.